MS
MICKAYLA STOGSDILL
ARNOLD & PORTER KAYE SCHOLER LLP · Washington, DC · registered since 2024
Registered · LDAActive
At a glance
Registered since
2024
Senate LDA system
Clients
7
last 3 years
Filings
18
5 agencies contacted
Activity
filings by quarter
Works on
Background
Government experience
Intern
Senate Health, Education, Labor, and Pensions Committee
2018
Disclosed on LD-2 filings
Career
AP
Specific issues
Issues related to implementation of the Inflation Reduction Act (IRA, P.L. 117-169).
Issues related to CMS coverage of anti-obesity medications, including the Treat and Reduce Obesity Act of 2023 (H.R. 4818 / S. 2407).
Issues related to pharmacy benefit managers (PBMs) and the 340B Program.
Issues related to pharmacy benefit managers (PBMs) and the 340B program. Issues related to the clinical and overall benefit of anti-obesity medications. Issues related to insulin pricing/affordability.
Issues related to manufacturing capacity and supply chain resiliency.
Issues related to access to plasma-derived products and implementation of the Inflation Reduction Act (IRA, P. L. 117-169), including the Preserving Life-saving Access to Specialty Medicines in America (PLASMA) Act (H.R. 6465 / S. 4741).
Clients
Filing history
PHARMAESSENTIA USA CORPORATION
NOVO NORDISK, INC.
AMERICAN COUNSELING ASSOCIATION
GRIFOLS SHARED SERVICES NORTH AMERICA, INC.
NOVO NORDISK A/S
PHARMAESSENTIA USA CORPORATION
PHARMAESSENTIA USA CORPORATION
NOVO NORDISK A/S
REGIONAL CANCER CARE ASSOCIATES
AMERICAN COUNSELING ASSOCIATION
GRIFOLS SHARED SERVICES NORTH AMERICA, INC.
PERRIGO COMPANY PLC